Safety of a Single, Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Retinitis Pigmentosa
Clinical trial NCT02320812 · COMPLETED
Trial details
- NCT number
- NCT02320812
- Sponsor
- jCyte, Inc
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2017-07-19
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.